Solventum Corporation, operating in the healthcare sector, presents a mixed investment opportunity with its multi-segment approach involving Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. While recent scores suggest a stable position, the company's fundamental rating indicates room for improvement in financial metrics.
Solventum shows balanced financial health, despite a moderate overall score. Below are the key financial ratios and their scores:
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
A comparison between the recent and past performances reveals a steady financial condition.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-01 | 3 | 5 | 4 | 3 | 1 | 2 | 2 |
| Previous | 0 | 5 | 4 | 3 | 1 | 2 | 2 |
Analysts present a promising outlook with a strong consensus on potential growth:
| High | Low | Median | Consensus |
|---|---|---|---|
| $103 | $75 | $82 | $86.67 |
The sentiment among analysts shows optimism with "Buy" ratings predominating:
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 3 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Solventum Corporation presents a multi-faceted investment profile, offering diverse opportunities across several medical and healthcare sectors. The stable historical financial rating coupled with a favorable analyst outlook provides a promising yet cautious investment landscape. While fundamental scores indicate potential areas for fiscal improvement, the company's diversified operations might offer resilience against market volatility. Investors should weigh the overall strong analyst sentiment against the moderate fiscal scores when considering investments.